Serial Cardiac MRI for Quantification of the Dynamics of Anthracycline‐Induced Subclinical Myocardial Injury

Abstract

BackgroundAnthracyclines are known to be associated with chemotherapy‐induced cardiotoxicity. Limited data focus on dynamic myocardial injury during the course of chemotherapy in patients with breast cancer.PurposeTo investigate the variation of tissue characterization and myocardial deformation derived by cardiac MRI during anthracycline chemotherapy.Study TypeProspective.PopulationFifty‐eight female breast cancer patients (mean age: 52.82 ± 2.61 years) were enrolled.Field Strength/SequenceA 3.0‐T, cardiac MRI including cine balanced steady‐state free precession, a modified Looker‐Locker inversion recovery (MOLLI), and a fast spin echo (FSE) T2‐weighted sequences were performed.AssessmentCardiac MRI was performed baseline and after two, four, and six cycles of chemotherapy. Assessment of global longitudinal strain (GLS), global circumstance strain (GCS), global radial strain (GRS), and strain rate (GLS‐s, GCS‐s, GRS‐s) and T1, T2 and T2* were accomplished by CVI42. The anthracycline dose and risk factors were also collected before each cardiac MRI.Statistical TestsAnalysis of variance (ANOVA) for repeated measures was used to compare the changes in LVEF cardiac function, strain and T1/T2/T2* parameters over time. Pearson correlation analyses were performed to estimate the potential associations between differences in myocardial characteristics (∆) and the chemotherapy cycle. A P value <0.05 was considered statistically significant.ResultsLVEF was not significantly different from pretreatment MRI regarding each cycle of chemotherapy (P = 0.54). Compared with baseline, patients had significantly lower GLS (−15.85% ± 0.83%, −14.50% ± 0.88%, −12.34% ± 1.01% vs. –18.82% ± 0.92%) and GLS‐s (−0.71% ± 0.07%, −0.65% ± 0.05%, −0.64% ± 0.04% vs. –0.95 ± 0.06%) and increased T2 values (57.21 ± 4.27 msec, 58.60 ± 3.93 msec, 58.10 ± 3.17 msec vs. 43.88 ± 3.28 msec) at two, four and six cycles of chemotherapy treatment. ∆GLS and ∆GLS‐s were significantly associated with the chemotherapy cycle (correlation coefficients for GLS = 0.75, GLS‐s = 0.75).Data ConclusionCardiac MRI can precisely detect the dynamic changes of anthracycline‐induced subclinical myocardial injury that is represented as a gradually decrease in GLS and GLS‐s. These parameters may provide new insight for monitoring risk and therapy in patients with breast cancer.Evidence Level2.Technical EfficacyStage 1.